Health Rounds: Hormone delivery via skin patch may ease prostate cancer treatment side effects
When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...
Immunotherapy reduces sunspots by 65% in cancer patients
University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...
A Timeline of Teddi Mellencamp’s Cancer Journey — and How Her Melanoma May Have Spread to Her Brain
After having 17 melanoma spots removed, ‘Real Housewives of Beverly Hills’ alum Teddi Mellencamp was diagnosed with multiple ...
News Medical on MSN2d
Immunotherapy reduces sunspots and skin cancer by 65%
University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.
Navigating advanced bladder cancer: One caregiver's journey
Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his abdomen after drinking water. It was just a fleeting moment; one he brushed ...
Yamasaki Facial Plastic Surgery: Harvard-Trained Facial Plastic Surgeon Dr. Yamasaki Highlights Techniques for Skin Cancer Reconstruction on the Face
Dr. Alisa Yamasaki employs advanced reconstruction techniques to restore facial aesthetics after skin cancer surgery in ...
Science Daily2d
AI unlocks genetic clues to personalize cancer treatment
A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...
AI-driven genetic analysis uncovers insights for personalized cancer treatment
A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
News Medical on MSN17h
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...